摘要 |
<p>The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.</p> |